Thangaiyan Rabi

1.3k total citations
22 papers, 1.0k citations indexed

About

Thangaiyan Rabi is a scholar working on Molecular Biology, Toxicology and Physiology. According to data from OpenAlex, Thangaiyan Rabi has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Toxicology and 4 papers in Physiology. Recurrent topics in Thangaiyan Rabi's work include Phytochemical compounds biological activities (9 papers), Natural product bioactivities and synthesis (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Thangaiyan Rabi is often cited by papers focused on Phytochemical compounds biological activities (9 papers), Natural product bioactivities and synthesis (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Thangaiyan Rabi collaborates with scholars based in United States, India and Switzerland. Thangaiyan Rabi's co-authors include Anupam Bishayee, Cheppail Ramachandran, Sipra Banerjee, Donald Poirier, Nam Deuk Kim, Robert E. Mansel, Rajendra G. Mehta, Ishak Neéman, Boris Kaplan and Ephraim Shmaya Lansky and has published in prestigious journals such as Journal of Bacteriology, Journal of Applied Physiology and International Journal of Cancer.

In The Last Decade

Thangaiyan Rabi

22 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thangaiyan Rabi United States 14 476 325 297 181 130 22 1.0k
Hanna Szaefer Poland 22 624 1.3× 162 0.5× 180 0.6× 266 1.5× 177 1.4× 51 1.3k
Norihiro Banno Japan 15 607 1.3× 126 0.4× 273 0.9× 175 1.0× 111 0.9× 15 1.0k
Barbara M. Schmidt United States 16 362 0.8× 102 0.3× 308 1.0× 214 1.2× 164 1.3× 25 1.0k
Arosha N. Wijewickreme Canada 12 467 1.0× 165 0.5× 202 0.7× 340 1.9× 102 0.8× 14 1.2k
Sofia Mitakou Greece 25 623 1.3× 258 0.8× 482 1.6× 290 1.6× 99 0.8× 52 1.5k
Keiko Iwashita Japan 11 426 0.9× 100 0.3× 205 0.7× 343 1.9× 101 0.8× 28 893
Shanggong Yu United States 14 372 0.8× 122 0.4× 276 0.9× 265 1.5× 93 0.7× 22 933
Akiko Kojima‐Yuasa Japan 22 507 1.1× 109 0.3× 250 0.8× 101 0.6× 211 1.6× 62 1.1k
Sayed A. El‐Toumy Egypt 19 325 0.7× 93 0.3× 361 1.2× 171 0.9× 134 1.0× 66 987
Nobuhiro Fukuda Japan 17 278 0.6× 263 0.8× 276 0.9× 85 0.5× 85 0.7× 52 1.1k

Countries citing papers authored by Thangaiyan Rabi

Since Specialization
Citations

This map shows the geographic impact of Thangaiyan Rabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thangaiyan Rabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thangaiyan Rabi more than expected).

Fields of papers citing papers by Thangaiyan Rabi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thangaiyan Rabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thangaiyan Rabi. The network helps show where Thangaiyan Rabi may publish in the future.

Co-authorship network of co-authors of Thangaiyan Rabi

This figure shows the co-authorship network connecting the top 25 collaborators of Thangaiyan Rabi. A scholar is included among the top collaborators of Thangaiyan Rabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thangaiyan Rabi. Thangaiyan Rabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rabi, Thangaiyan & Carlo V. Catapano. (2016). Aphanin, a triterpenoid from Amoora rohituka inhibits K-Ras mutant activity and STAT3 in pancreatic carcinoma cells. Tumor Biology. 37(9). 12455–12464. 13 indexed citations
2.
Rabi, Thangaiyan, et al.. (2013). Novel synthetic oleanane triterpenoid AMR-MeOAc inhibits K-Ras through ERK, Akt and survivin in pancreatic cancer cells. Phytomedicine. 21(4). 491–496. 3 indexed citations
3.
Bishayee, Anupam & Thangaiyan Rabi. (2009). d -Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis. Journal of Carcinogenesis. 8(1). 9–9. 98 indexed citations
5.
Rabi, Thangaiyan. (2008). Dietary terpenoids and prostate cancer chemoprevention. Frontiers in bioscience. Volume(13). 3457–3457. 24 indexed citations
6.
Rabi, Thangaiyan & Anupam Bishayee. (2008). Terpenoids and breast cancer chemoprevention. Breast Cancer Research and Treatment. 115(2). 223–239. 174 indexed citations
7.
Rabi, Thangaiyan, Sanjeev Shukla, & Sanjay Gupta. (2008). Betulinic acid suppresses constitutive and TNFα‐induced NF‐κB activation and induces apoptosis in human prostate carcinoma PC‐3 cells. Molecular Carcinogenesis. 47(12). 964–973. 70 indexed citations
9.
Wang, Liming, Nandan Bhattacharyya, Thangaiyan Rabi, Li Wang, & Sipra Banerjee. (2006). Mammary carcinogenesis in transgenic mice expressing a dominant-negative mutant of DNA polymerase β in their mammary glands. Carcinogenesis. 28(6). 1356–1363. 8 indexed citations
10.
Rabi, Thangaiyan, Liming Wang, & Sipra Banerjee. (2006). Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cells. Breast Cancer Research and Treatment. 101(1). 27–36. 27 indexed citations
11.
Ramachandran, Cheppail, Thangaiyan Rabi, Hugo B. Fonseca, Steven J. Melnick, & Enrique Escalon. (2003). Novel plant triterpenoid drug amooranin overcomes multidrug resistance in human leukemia and colon carcinoma cell lines. International Journal of Cancer. 105(6). 784–789. 34 indexed citations
12.
Rabi, Thangaiyan, et al.. (2003). Novel Drug Amooranin Induces Apoptosis Through Caspase Activity in Human Breast Carcinoma Cell Lines. Breast Cancer Research and Treatment. 80(3). 321–330. 36 indexed citations
13.
Kim, Nam Deuk, Rajendra G. Mehta, Weiping Yu, et al.. (2002). Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Research and Treatment. 71(3). 203–217. 354 indexed citations
14.
Rabi, Thangaiyan, et al.. (2002). Cytotoxic activity of amooranin and its derivatives. Phytotherapy Research. 16(S1). 84–86. 23 indexed citations
15.
Rabi, Thangaiyan, et al.. (1995). Antitumor and Cytotoxic Investigation of Amoora Rohituka. International Journal of Pharmacognosy. 33(4). 359–361. 29 indexed citations
16.
Rabi, Thangaiyan, et al.. (1994). Influence Of Amoora Rohituka On MCF-7 Human Mammary Adenocarcinoma Cells In Vitro. Indian Journal of Pharmaceutical Sciences. 56(4). 136. 4 indexed citations
17.
Li, Shun, Thangaiyan Rabi, & J A DeMoss. (1985). Delineation of two distinct regulatory domains in the 5' region of the nar operon of Escherichia coli. Journal of Bacteriology. 164(1). 25–32. 33 indexed citations
18.
Rabi, Thangaiyan, Y Cassuto, & Alisa Gutman. (1977). Lipolysis in brown adipose tissue of cold- and heat-acclimated hamsters. Journal of Applied Physiology. 43(6). 1007–1011. 9 indexed citations
19.
Rabi, Thangaiyan & Y Cassuto. (1976). Metabolic adaptations in brown adipose tissue of the hamster in extreme ambient temperatures. American Journal of Physiology-Legacy Content. 231(1). 153–160. 11 indexed citations
20.
Rabi, Thangaiyan & Y Cassuto. (1976). Metabolic activity of brown adipose tissue in T3-treated hamsters. American Journal of Physiology-Legacy Content. 231(1). 161–163. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026